Diagnostic and treatment outcomes of patients with pulmonary tuberculosis in the first year of COVID-19 pandemic

Basit Öğe Kaydı
dc.authoridTanriverdi, Elif Seren/0000-0002-0449-0356
dc.authoridOtlu, Baris/0000-0002-6220-0521
dc.authorwosidTanriverdi, Elif Seren/ABE-4472-2021
dc.contributor.authorYakupogullari, Yusuf
dc.contributor.authorErmis, Hilal
dc.contributor.authorKazgan, Zeynep
dc.contributor.authorOtlu, Baris
dc.contributor.authorBayindir, Yasar
dc.contributor.authorGulbas, Gazi
dc.contributor.authorTanriverdi, Elif
dc.date.accessioned2024-08-04T20:53:02Z
dc.date.available2024-08-04T20:53:02Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground: The COVID-19 pandemic has put a significant strain on human life and health care systems, however, little is known about its impact on tuberculosis (TB) patients. Aims: To assess the impact of COVID-19 pandemic on pulmonary tuberculosis (PTB) diagnosis, treatment and patient outcomes, using the WHO definitions. Methods: A cross-sectional study was conducted in Malatya region, Turkey (population 800 000). Data on regional PTB test numbers, case notification rates and PTB patients' clinical characteristics and treatment outcomes were collected. Data from the first pandemic year (2020) were compared to data from the previous 3 years (2017-2019). The attitudes and experiences of patients were analysed. Results: Despite a non-significant 22% decrease in annual PTB case notifications (P = 0.317), the number of TB tests performed (P = 0.001) and PTB patients evaluated (P = 0.001) decreased significantly during the pandemic year compared with the previous 3 years. The proportion of patients with high (3/4+) sputum acid-fast bacilli grades (P = 0.001), TB relapse (P = 0.022) and treatment failure (P = 0.018) increased significantly. The median 64.5-day treatment delay detected in 2017-2019 increased significantly to 113.5 days in 2020 (P = 0.001), due primarily to patients' reluctance to visit a health care facility. Conclusion: In addition to the problems with case detection, this study shows notable deterioration in several indicators related to the severity, contagiousness and poor outcomes of TB, which had already been suppressed for decades.en_US
dc.identifier.doi10.26719/emhj.22.060
dc.identifier.endpage689en_US
dc.identifier.issn1020-3397
dc.identifier.issn1687-1634
dc.identifier.issue9en_US
dc.identifier.pmid36205207en_US
dc.identifier.scopus2-s2.0-85139138052en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage682en_US
dc.identifier.urihttps://doi.org/10.26719/emhj.22.060
dc.identifier.urihttps://hdl.handle.net/11616/100921
dc.identifier.volume28en_US
dc.identifier.wosWOS:000965192300004en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWho Eastern Mediterranean Regional Officeen_US
dc.relation.ispartofEastern Mediterranean Health Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjectpulmonary tuberculosisen_US
dc.subjectself-reported symptomsen_US
dc.subjectpredictorsen_US
dc.subjectsensitivityen_US
dc.subjectspecificityen_US
dc.titleDiagnostic and treatment outcomes of patients with pulmonary tuberculosis in the first year of COVID-19 pandemicen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu